section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: hypertension

Derm: cutaneous reactions

GI: dyspepsia

Local: infusion site swelling

MS: arthralgia

Neuro: headache, malaise

Misc: fever, ANAPHYLAXIS

Interactions

Drug-drug:

Availability

Route/Dosage

US Brand Names

Elaprase

Action

  • Replaces an enzyme not present in Hunter syndrome. Absence of the enzyme results in cellular accumulation of aminoglycans, organomegaly and organ dysfunction.
Therapeutic effects:
  • Improved walking capacity.

Classifications

Therapeutic Classification: replacement enzyme

Pharmacologic Classification: enzymes

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-Life: 44–48 min.

Time/Action Profile

ROUTEONSETPEAKDURATION
IVrapidend of infusionunknown

Patient/Family Teaching

Pronunciation

i-dur-SUL-fase

Code

NDC Code